YCH Group awarded Good Distribution Practice (GDP) certification

Oct 23, 2006 12:00:00 AM

23 October 2006

YCH Group ("YCH") has been awarded the Good Distribution Practice (GDP) certification by the Health Sciences Authority (HSA). This certification relates to the storage and distribution of medicinal products or active pharmaceutical ingredients, attesting to YCH�s conformity with HSA�s Good Distribution Practice Standard.

To achieve the GDP certification, the organization needs to demonstrate capability in managing the quality and integrity of the medicinal products or active pharmaceutical ingredients throughout the distribution chain. A stringent audit was carried out by HSA on YCH�s distribution facility and quality systems to ensure its compliance to Good Distribution Standards. YCH has shown compliance in the key areas of focus which include training to develop competent personnel, cleaning and sanitization, pest control, receiving, handling, delivery and disposal of products, handling of complaints, returned goods, product recalls and self inspection.

This certification serves as a key mandate for YCH to expand its service offerings more comprehensively into the Healthcare and Pharmaceutical industry, as this bears strong testimony to YCH�s capabilities as a competent healthcare supply chain partner. YCH was able to achieve this GDP certification under unprecedented conditions, overcoming the stringent audit requirements within a very short time frame. This is largely due to YCH�s consistently high standards and efforts in developing and managing world-class supply chain operations across industries throughout Asia Pacific.

YCH awarded GDP certification by HSA in compliance with stringent standards to facilitate the sales, supply and exportation of their medicinal products and active pharmaceutical ingredients

YCH's specialized temperature-controlled storage rooms, strong IT solutions, extensive healthcare track record and rigorous process-oriented best practices, alongside with this GDP certification will enable it to position itself as a strong and competent partner for all our world-class pharmaceutical customers such as Stiefel Laboratories and GlaxoSmithKline, at the heart of the healthcare supply chain - where supplychain connectsTM.